BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Fatty acid metabolic process
,
Hepatitis
,
Endothelial cell
,
Hematopoietic cell
,
IL1A
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
MSL
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Whole blood
Thymus gland
Atrioventricular node
Lymph nodes
Tonsil
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Loading...
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Loading...
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
Loading...
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Effect of MSL1, MSL3 and MOF RNAi knock downs in Drosophila SL-2 and Kc cells
Sxl and MSL2 knockdown in Kc cells
Embryonic stem WT26 cells depleted of Mof, Msl1, Msl2 or Nsl3
Topoisomerase II RNAi knockdown in S2 cells
MSL2 KO in male third instar larvae
Explore Curated Studies Results
Literature
Most Relevant Literature
Msl3 promotes germline stem cell differentiation in female Drosophila.
PEG3 control on the mammalian MSL complex.
Loss Of Chromodomain of Male-Specific Lethal 3 (MSL3) Does Not Affect Spermatogenesis In Rodents.
Structural basis for MOF and MSL3 recruitment into the dosage compensation complex by MSL1.
Distinct contributions of MSL complex subunits to the transcriptional enhancement responsible for do…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
A Phase II/III Trial of Human Anti-CMV Monoclonal Antibody MSL 109 (MACRT)
Phase I/II Study of Human Anti-Cytomegalovirus (CMV) Monoclonal Antibody MSL-109 in Newborns With Sy…
Evaluation of Safety and Efficiency of Metreleptin Treatment for Patients With Multiple Symmetric Li…
A Phase I/II Trial to Assess the Safety and Tolerance of Escalating Doses of a Human Anti-Cytomegalo…
A Randomized, Phase I/II Trial to Assess the Safety and Antiviral Effects of Escalating Doses of A H…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ